Skip to Main content Skip to Navigation
Journal articles

PAK1-Dependent Antitumor Effect of AAC-11‒Derived Peptides on Sézary Syndrome Malignant CD4+ T Lymphocytes

Abstract : Sézary syndrome is an aggressive form of cutaneous T-cell lymphoma characterized by the presence of a malignant CD4+ T-cell clone in both blood and skin. Its pathophysiology is still poorly understood, and the development of targeted therapies is hampered by the absence of specific target proteins. AAC-11 plays important roles in cancer cell progression and survival and thus has been considered as an anticancer therapeutic target. In this study, we show that a peptide called RT39, comprising a portion of AAC-11‒binding site to its protein partners coupled to the penetratin sequence, induces the specific elimination of the malignant T-cell clone both ex vivo on the circulating cells of patients with Sézary syndrome and in vivo in a subcutaneous xenograft mouse model. RT39 acts by direct binding to PAK1 that is overexpressed, located in the plasma membrane, and constitutively activated in Sézary cells, resulting in their selective depletion by membranolysis. Along with the absence of toxicity, our preclinical efficacy evidence suggests that RT39 might represent a promising alternative therapeutic tool for Sézary syndrome because it spares the nonmalignant immune cells and, contrary to antibody-based immunotherapies, does not require the mobilization of the cellular immunity that shows heavy deficiencies at advanced stages of the disease.
Document type :
Journal articles
Complete list of metadata

https://www.hal.inserm.fr/inserm-03431712
Contributor : Anne Marie-Cardine Connect in order to contact the contributor
Submitted on : Tuesday, November 16, 2021 - 7:17:57 PM
Last modification on : Wednesday, December 1, 2021 - 1:40:02 PM

File

 Restricted access
To satisfy the distribution rights of the publisher, the document is embargoed until : jamais

Please log in to resquest access to the document

Identifiers

Collections

Citation

Justine Habault, Nicolas Thonnart, Ewa Pasquereau-Kotula, Martine Bagot, Armand Bensussan, et al.. PAK1-Dependent Antitumor Effect of AAC-11‒Derived Peptides on Sézary Syndrome Malignant CD4+ T Lymphocytes. Journal of Investigative Dermatology, Nature Publishing Group, 2021, 141 (9), pp.2261-2271.e5. ⟨10.1016/j.jid.2021.01.033⟩. ⟨inserm-03431712⟩

Share

Metrics

Record views

11